Tag: LILLY DRN
Amgen stock falls as analysts mull over weight loss drug’s bone...
Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental...
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after...
Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024.Picture Alliance | Picture Alliance...
Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s...
Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supply of both...
Eli Lilly stock tumbles 10% after drug giant misses estimates and...
Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023.Mike Blake | ReutersEli Lilly on Wednesday fell short of profit...
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic,...
Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its...
Eli Lilly to build $4.5 billion research and manufacturing center to...
Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines. The facility, called the Lilly...
